Takeda Pharmaceutical Company Limited Finance Costs
Takeda Pharmaceutical Company Limited (TAK) reported Finance Costs of JPY 210.06 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2025-06-25
| Period end | Finance Costs 12 month |
|---|---|
| 2025-03-31 | 210.06B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 219.85B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 169.70B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 166.61B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 248.63B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 165.01B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 83.29B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 31.93B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 23.25B JPY 20-F · filed 2019-06-27 |